vTv Therapeutics Inc.
NASDAQVTVT short interest surges 44% in one week to 3.47% of float, as biotech rallies ahead of earnings today.
Snapshot as of 14 May 2026
vTv Therapeutics heads into its May 14 earnings release after posting Q1 results that landed well above expectations on both the top and bottom lines — a print that looks set to unwind the short-side positioning that…
vTv Therapeutics just reported Q1 2026 results that blew past every estimate on the Street, landing EPS of $1.65 against a consensus of -$0.10 and revenue of $36.8M against a $20M forecast — and the timing couldn't be…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for VTVT — free to start on ORTEX.
Sign up for free →Open VTVT on ORTEX